Medicenna Therapeutics Corp. (MDNAF)
OTCMKTS · Delayed Price · Currency is USD
0.8000
+0.0220 (2.83%)
Aug 29, 2025, 4:00 PM EDT
Medicenna Therapeutics Market Cap
Medicenna Therapeutics has a market cap or net worth of $66.18 million as of August 29, 2025. Its market cap has decreased by -44.67% in one year.
Market Cap
66.18M
Enterprise Value
51.40M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.80
Market Cap Chart
Since March 8, 2017, Medicenna Therapeutics's market cap has increased from 48.70M to 66.18M, an increase of 35.89%. That is a compound annual growth rate of 3.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 29, 2025 | 66.18M | -26.22% |
| Dec 31, 2024 | 89.69M | 305.00% |
| Dec 29, 2023 | 22.15M | -32.75% |
| Dec 30, 2022 | 32.93M | -63.24% |
| Dec 31, 2021 | 89.58M | -62.05% |
| Dec 31, 2020 | 236.06M | 163.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 8, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 832.17M |
| Elite Pharmaceuticals | 734.61M |
| Tian'an Technology Group | 682.77M |
| Glass House Brands | 655.63M |
| Northwest Biotherapeutics | 448.50M |
| CytoDyn | 376.00M |
| American Oncology Network | 343.87M |